US Patent 11918585 Formulations of an AXL/MER inhibitor
Patent 11918585 was granted and assigned to Incyte on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+308 characters)
US Patent 11918585 Formulations of an AXL/MER inhibitor
Article
Patent abstract
The present application relates to pharmaceutical formulations and dosage forms of an AXL/MER inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of AXL/MER mediated diseases such as cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Francis X. Muller0
William L. Rocco0
Date of Patent
March 5, 2024
0Patent Application Number
175632820
Date Filed
December 28, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11918585 Formulations of an AXL/MER inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
